Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Blauvelt, Andrew, de Bruin-Weller, Marjolein, Gooderham, Melinda, Cather, Jennifer C, Weisman, Jamie, Pariser, David, Simpson, Eric L, Papp, Kim A, Hong, H Chih-Ho, Rubel, Diana, Foley, Peter, Prens, Errol, Griffiths, Christopher E M, Etoh, Takafumi, Pinto, Pedro Herranz, Pujol, Ramon M, Szepietowski, Jacek C, Ettler, Karel, Kemény, Lajos, Zhu, Xiaoping, Akinlade, Bolanle, Hultsch, Thomas, Mastey, Vera, Gadkari, Abhijit, Eckert, Laurent, Amin, Nikhil, Graham, Neil M H, Pirozzi, Gianluca, Stahl, Neil, Yancopoulos, George D, Shumel, Brad: Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
LANCET, 389 (10086). pp. 2287-2303. ISSN 0140-6736 (2017)

[img] Text
3230565_Blauvelt.pdf - Published Version
Korlátozott. Repository staff only

Download (561kB) | Request a copy
Item Type: Article
Journal or Publication Title: LANCET
Date: 2017
Volume: 389
Number: 10086
Page Range: pp. 2287-2303
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 3230565
DOI id: https://doi.org/10.1016/S0140-6736(17)31191-1
Date Deposited: 2017. Oct. 19. 16:00
Last Modified: 2019. Oct. 22. 14:53
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11568
Web of Science® Times Cited: 242 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year